Clinical Trials Browser

Active not recruiting × Advanced Solid Tumors × spartalizumab × Clear all

NCT04058756 2025-10-07

Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors